Digitisation | January 14, 2022
Hekka Labs introduces decentralized chronic disease data management in South Asia
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
Clears major obesity endpoints at 80 weeks
The approval has been secured in partnership with Yabao Pharmaceuticals, a major player in China’s paediatric medicine segment
The country’s strength lies not just in technology availability but in adoption behaviour
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
Subscribe To Our Newsletter & Stay Updated
